FDA Approved: CAYSTON — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA granted original approval to Cayston (aztreonam for inhalation solution) from Gilead for the treatment of cystic fibrosis patients chronically infected …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

ORIG AP for CAYSTON (AZTREONAM)